drugset / Trial / NCT03241303
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
RandomizedCrossoverTriple-blindBasic science
Summary
Investigation of GLP-1 signalling in the glucose-lowering effect of increased carbohydrate content in the distal small intestines induced by alpha-glucosidase inhibition during meal ingestion in patients with type 2 diabetes
Timeline
- Start
- 2017-08-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 50 mg | Oral |
| Subject | Acarbose | Unknown | 100 mg | Oral |
| Subject | Avexitide | Peptide | — | — |